8 / 12
Page 46
Notes:
allied
academies
J Gastroenterol Dig Dis 2017 | Volume 2, Issue 3
World Gastroenterological &
Gastroenterology and Endoscopy
October 30-31, 2017 | Toronto, Canada
World Congress on
T
his program will review the best available evidence of
the use of dietary supplements (herbals, nutraceuticals,
probiotics, fish oils) for the management of IBD.
Inflammatory bowel disease (IBD) is a disorder characterized
by idiopathic chronic intestinal inflammation associated with
the utilization of costly medications, disease and medication-
associated complications, hospitalizations, poor quality of
life, surgical procedures, malnutrition, and much more. IBD
is estimated to afflict 1.2 million Americans with 21-60%
of IBD patient have utilized at least one form of CAM with
dietary supplements and altered diet constituting the top
modalities with optimum symptom control as the rationale.
Dietary supplements and altered diets are promoted on
the Internet by healthcare practitioners and even non-
licensed individuals often without supporting evidence
and place patients at risk due to macronutrient restriction
(diet) or toxicity (dietary supplements). IBD patients often
turn to their physician whether dietary supplements are
useful for control of their disease symptoms. The goal of
this program is to provide an evidence-based review of
dietary supplements in the management of IBD. To define
the pathophysiology of inflammatory bowel disease, the
potential mechanisms of nutritional (oral diet, dietary
supplements) disease pathogenesis and their patterns of
utilization in this population is to be reviewed, the evidence
of dietary supplements and altered diets in the management
of inflammatory bowel disease.
e:
gmullin1@jhmi.eduDietary supplements and altered diets for IBD: Hype or help?
Gerard E Mullin
Johns Hopkins University School of Medicine, USA